Equitec Proprietary Markets’s Biogen BIIB Stock Holding History

Equitec Proprietary Markets’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-113	Closed	-$27K	–	278
2021 Q4	$27K	Buy	+113	New	+$29.1K	﹤0.01%	279
2016 Q3	–	Sell	-100	Closed	-$24K	–	137
2016 Q2	$24K	Buy	100 +95	+1,900%	+$25K	﹤0.01%	125
2016 Q1	$1K	Buy	+5	New	+$1.32K	﹤0.01%	145
2015 Q2	–	Sell	-1,200	Closed	-$507K	–	156
2015 Q1	$507K	Sell	1,200 -932	-44%	-$367K	0.04%	85
2014 Q4	$724K	Buy	+2,132	New	+$690K	0.03%	123

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Equitec Proprietary Markets's BIIB Position: Q1 2022 in Review

Equitec Proprietary Markets sold out of Biogen (BIIB) in Q1 2022, closing a stake of 113 shares — an estimated $27K sold.

Equitec Proprietary Markets first reported a position in BIIB in Q4 2014 and held it in 5 quarters. The position peaked at $724K in Q4 2014. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

Equitec Proprietary Markets reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
Equitec Proprietary Markets sold 113 Biogen shares in Q1 2022, an estimated $27K.
Equitec Proprietary Markets first reported a position in Biogen in Q4 2014 and held it in 5 quarters.
Equitec Proprietary Markets's Biogen position peaked at $724K in Q4 2014.
951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Equitec Proprietary Markets's 13F filing for Q1 2022, filed 22 Apr 2022.